At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 383 enrolled
Drug / intervention
LEO 43204 gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up
In Brief
A Phase 3 clinical trial evaluating LEO 43204 gel and Vehicle gel for Actinic Keratosis. Completed, enrolled 383 participants across 1 site.
Detailed Summary
The objective of the trial is to compare the short term efficacy of LEO 43204 gel with vehicle gel in AK on face or chest when applied topically once daily for 3 consecutive days as field treatment
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsActinic Keratosis
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 2015
Enrollment StartNov 2015
Primary CompletionAug 2016
Study CompletionAug 2017
TodayJul 2026
First PostedSep 15, 2015
Enrollment StartNov 13, 2015
Primary CompletionAug 5, 2016
Study CompletionAug 10, 2017
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 10.8 years ago
Interventions
LEO 43204 geldrug
Vehicle geldrug